Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Avian Flu Treatment Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market for treating avian flu has significantly expanded in the past few years. There is an expected escalation from $12.59 billion in 2024 to $13.77 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Factors such as the increased demand for bird flu treatment, the implementation of preventative measures against bird flu, the wider availability of treatment choices, greater healthcare infrastructure investments, and amplified demand for poultry for eating habits, have contributed to the growth experienced in the historical period.
A significant increase in the market size of avian flu treatments is anticipated in the upcoming years. The market is projected to attain a value of$19.23 billion in 2029, registering a compound annual growth rate (CAGR) of 8.7%. This surge during the projected period can be credited to a rise in awareness and diagnosis, government strategies for handling pandemics, increased investments in research and development, demand for effective therapies against avian flu, and thorough research and development activities. Noteworthy trends during this period consist of the creation of unique therapeutic methods, innovations and technological advancements in the future, cooperative research initiatives, development of new businesses and investment prospects, alongside the application of telemedicine and distant consultations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp
What External and Internal Drivers Are Contributing to the Growth of theAvian Flu Treatment Market?
The expansion of the avian flu treatment market is projected to be fueled by the increasing awareness and diagnosis. Understanding a condition is what awareness is all about, whereas diagnosis involves identifying a specific issue based on that understanding. Public health protection, the prevention of possible pandemics, and the prevention of substantial economic losses in poultry populations are all factors driving the demand for avian flu treatment. To ensure effective avian flu treatment, it is critical to raise awareness and diagnose early, allowing for quick actions and containment to stop the disease from spreading. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 8000 individuals in the US were actively monitored from February 9, 2022, to March 29, 2024, following exposure to animals suspected of being infected with the HPAI A (H5N1) virus. Consequently, the avian flu treatment market is experiencing growth due to the rising awareness and diagnosis.
What Segment Types Define the Avian Flu Treatment Market Structure?
The avian flu treatmentmarket covered in this report is segmented –
1) By Type: Antibiotics; Vaccines; Antiviral Agents; Immunoglobulins
2) By Distribution Channel: Online Pharmacies; Offline Pharmacies
3) By End User: Hospital; Institutional Health Centers; Clinics
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Tetracycline Antibiotics; Penicillin-Based Antibiotics; Macrolide Antibiotics; Cephalosporins; Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Subunit Vaccines; Dna Vaccines; Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir); M2 Ion Channel Inhibitors (Amantadine); Polymerase Inhibitors; Protease Inhibitors; Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig); Monoclonal Antibodies; Hyperimmune Serum; Polyvalent Immunoglobulins; Avian Flu-Specific Immunoglobulins
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Avian Flu Treatment Market?
North America was the largest region in the avian flu treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Avian Flu Treatment Market?
Leading firms in the avian flu treatment sector are prioritizing the formation of partnerships to amplify efficiency and expedite the production of new therapies. These partnerships combine the efforts of pharmaceutical corporations, research institutions, and government bodies to merge resources, exchange knowledge, and carry out pioneering clinical trials. For example, in April 2024, CureVac N.V., a biotechnology firm based in Germany, collaborated with GSK plc, a pharmaceutical company from the UK, to develop an experimental influenza A (H5N1) pre-pandemic vaccine candidate. This vaccine is intended to combat the possible future pandemic risks presented by the H5N1 avian influenza virus. This partnership’s goal is to verify the safety, reactogenicity, and immune response of this monovalent vaccine candidate that embodies an influenza A H5-antigen using CureVac’s proprietary second-generation mRNA backbone. A combined Phase 1/2 study will estimate the safety and efficacy of the vaccine candidate in healthy adults aged 18-64, as well as senior adults aged 65-85.
View the full report here:
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report
What Is the Definition of the Avian Flu Treatment Market?
Avian flu treatment refers to the medical interventions and strategies aimed at managing and alleviating the symptoms of avian influenza, commonly known as bird flu, in infected individuals. Avian influenza is caused by viruses that primarily infect birds, but certain strains, such as H5N1 and H7N9, have been known to infect humans and cause severe illness or even death in some cases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16352
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model